NCT02323009

Brief Summary

This is a study to evaluate whether PEEP adjusted by use of an esophageal balloon to overcome negative transpulmonary pressure; or adjusted by use of "CStat" to achieve the best effective static compliance will have any effect on outcomes with respect to ventilator weaning in tracheotomized morbidly obese patients (BMI \>=40) with at least one failed prior weaning attempt.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 12, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 23, 2014

Completed
Last Updated

December 23, 2014

Status Verified

December 1, 2014

Enrollment Period

2.8 years

First QC Date

December 12, 2014

Last Update Submit

December 17, 2014

Conditions

Keywords

Transpulmonary pressureEsophageal balloonEsophageal pressure monitoring deviceCstatStatic effective complianceVentilator weaningMorbidly Obese Ventilator Dependent Tracheotomized Patients

Outcome Measures

Primary Outcomes (1)

  • Number of patients weaned by day 30

    A patient was considered successfully weaned and "ventilator independent" if they were spontaneously breathing without ventilator support for at least 24 hours, and remained off the ventilator by day 30. If ventilator support was subsequently required, the patient was returned to their original group and considered not weaned. The patients were considered to be weaned or not, after a period of thirty days.

    30-days

Secondary Outcomes (1)

  • Time to wean

    30-days

Study Arms (3)

Esophageal balloon Arm

ACTIVE COMPARATOR

Patients in this arm were randomly assigned to have their PEEP adjusted to maintain a positive transpulmonary pressure (0 to 10 cm H20).

Device: Esophageal Balloon

Cstat Arm

ACTIVE COMPARATOR

Patients in this arm had their PEEP adjusted to achieve the best static effective compliance (CStat).

Other: Cstat

Historic Controls

NO INTERVENTION

These were historic controls with similar patient characteristics weaned by traditional methods in the 2-year period prior to the start of the study.

Interventions

Esophageal balloon was used to measure esophageal pressure (Paux) which was used as an estimate of pleural pressure. Transpulmonary pressure (Ptp) was calculated as the difference between airway pressure (Pao) and Paux. Applied PEEP was then adjusted to overcome negative Ptp which we maintained between 0 to 10 cm H20. All measurements were made at end-expiration.

Esophageal balloon Arm
CstatOTHER

PEEP was adjusted to achieve the best CStat in this group of patients

Cstat Arm

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Morbidly obese patients with BMI of 40 or greater
  • Ventilator dependent patients (defined as at least one prior failure at weaning)
  • Tracheotomized
  • No active underlying lung disease that would preclude ventilator weaning
  • Stable hemodynamics
  • Patient/ family able to give consent
  • No naso-facial abnormalities that would interfere with placement of an esophageal balloon
  • Fio2 \<= 60%
  • Patient able to tolerate Pressure Support ventilation

You may not qualify if:

  • Lack of consent
  • Patient deemed not weanable from mechanical ventilation as per the clinical judgement of the pulmonary physician
  • Significant lung, heart or neuromuscular disease that would interfere with or preclude ventilator weaning, including an active ongoing lung infection.
  • Contraindications to placement of an esophageal pressure monitoring device - such as ulcerations, tumors, diverticulitis, uncontrolled bleeding varices, sinusitis, epistaxis or recent nasopharyngeal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vidant Medical Center

Greenville, North Carolina, 27834, United States

Location

Related Publications (12)

  • Talmor D, Sarge T, O'Donnell CR, Ritz R, Malhotra A, Lisbon A, Loring SH. Esophageal and transpulmonary pressures in acute respiratory failure. Crit Care Med. 2006 May;34(5):1389-94. doi: 10.1097/01.CCM.0000215515.49001.A2.

    PMID: 16540960BACKGROUND
  • Talmor D, Sarge T, Malhotra A, O'Donnell CR, Ritz R, Lisbon A, Novack V, Loring SH. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008 Nov 13;359(20):2095-104. doi: 10.1056/NEJMoa0708638. Epub 2008 Nov 11.

    PMID: 19001507BACKGROUND
  • Talmor DS, Fessler HE. Are esophageal pressure measurements important in clinical decision-making in mechanically ventilated patients? Respir Care. 2010 Feb;55(2):162-72; discussion 172-4.

    PMID: 20105342BACKGROUND
  • Loring SH, Pecchiari M, Della Valle P, Monaco A, Gentile G, D'Angelo E. Maintaining end-expiratory transpulmonary pressure prevents worsening of ventilator-induced lung injury caused by chest wall constriction in surfactant-depleted rats. Crit Care Med. 2010 Dec;38(12):2358-64. doi: 10.1097/CCM.0b013e3181fa02b8.

    PMID: 20890197BACKGROUND
  • Loring SH, O'Donnell CR, Behazin N, Malhotra A, Sarge T, Ritz R, Novack V, Talmor D. Esophageal pressures in acute lung injury: do they represent artifact or useful information about transpulmonary pressure, chest wall mechanics, and lung stress? J Appl Physiol (1985). 2010 Mar;108(3):515-22. doi: 10.1152/japplphysiol.00835.2009. Epub 2009 Dec 17.

    PMID: 20019160BACKGROUND
  • Hedenstierna G. Esophageal pressure: benefit and limitations. Minerva Anestesiol. 2012 Aug;78(8):959-66. Epub 2012 Jun 14.

    PMID: 22699701BACKGROUND
  • Owens RL, Campana LM, Hess L, Eckert DJ, Loring SH, Malhotra A. Sitting and supine esophageal pressures in overweight and obese subjects. Obesity (Silver Spring). 2012 Dec;20(12):2354-60. doi: 10.1038/oby.2012.120. Epub 2012 May 4.

    PMID: 22695479BACKGROUND
  • MEAD J, GAENSLER EA. Esophageal and pleural pressures in man, upright and supine. J Appl Physiol. 1959 Jan;14(1):81-3. doi: 10.1152/jappl.1959.14.1.81. No abstract available.

    PMID: 13630830BACKGROUND
  • Piraino T, Cook DJ. Optimal PEEP guided by esophageal balloon manometry. Respir Care. 2011 Apr;56(4):510-3. doi: 10.4187/respcare.00815. Epub 2011 Jan 21.

    PMID: 21255501BACKGROUND
  • Washko GR, O'Donnell CR, Loring SH. Volume-related and volume-independent effects of posture on esophageal and transpulmonary pressures in healthy subjects. J Appl Physiol (1985). 2006 Mar;100(3):753-8. doi: 10.1152/japplphysiol.00697.2005. Epub 2005 Nov 23.

    PMID: 16306256BACKGROUND
  • Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707. No abstract available.

    PMID: 24283226BACKGROUND
  • Obi ON, Mazer M, Bangley C, Kassabo Z, Saadah K, Trainor W, Stephens K, Rice PL, Shaw R. Obesity and Weaning from Mechanical Ventilation-An Exploratory Study. Clin Med Insights Circ Respir Pulm Med. 2018 Sep 18;12:1179548418801004. doi: 10.1177/1179548418801004. eCollection 2018.

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Robert Shaw, MD

    East Carolina University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Robert Shaw, MD (Principal Investigator)

Study Record Dates

First Submitted

December 12, 2014

First Posted

December 23, 2014

Study Start

January 1, 2011

Primary Completion

October 1, 2013

Study Completion

November 1, 2013

Last Updated

December 23, 2014

Record last verified: 2014-12

Locations